The global biopharmaceutical market size was estimated at USD 452.21 billion in 2024 and is projected to grow at a CAGR of 8.87% from 2025 to 2030. The biopharmaceutical industry’s growth is driven by the increasing demand for targeted therapies, advancements in biotechnology, risi... Read More »
March 2025The global acute myeloid leukemia treatment market size was estimated at USD 3.47 billion in 2024 and is projected to grow at a CAGR of 10.6% from 2025 to 2030. Rising incidences of acute myeloid leukemia and increasing need for advanced therapeutics are attributed to factors such as gen... Read More »
March 2025The global drug discovery informatics market size was valued at USD 3.65 billion in 2024 and is anticipated to grow at a CAGR of 11.6% from 2025 to 2030. This can be attributed to various factors, including advancements in high-performance computing and web services, increased adoption o... Read More »
March 2025The U.S. cannabis market size was estimated at USD 38.50 billion in 2024 and is expected to grow at a CAGR of 11.51% from 2025 to 2030. In the U.S., cannabis is used in the pharmaceutical, cosmetic, and food & beverage industries. Growing acceptance of its use for medical purposes an... Read More »
March 2025The global fondaparinux market size was valued at USD 688.0 million in 2024 and is projected to grow at a CAGR of 6.3% from 2025 to 2030. A steadily aging population globally is anticipated to heighten the prevalence of health disorders and highlight the need for surgical procedures, whi... Read More »
March 2025The global dopamine agonist market size was estimated at USD 1.31 billion in 2024 and is projected to grow at a CAGR of 5.70% from 2025 to 2030. The market is driven by several key factors, primarily the rising prevalence of Parkinson’s disease, restless leg syndrome, and other neu... Read More »
February 2025The global metastatic lung adenocarcinoma treatment market size was valued at USD 4.90 billion in 2024 and is expected to grow at a CAGR of 11.3% from 2025 to 2030. This growth is fueled by the rising incidence of lung cancer coupled with advancements in treatment options. As lung cancer... Read More »
February 2025The global lung adenocarcinoma treatment market size was estimated at USD 6.08 billion in 2024 and is projected to grow at a CAGR of 10.7% from 2025 to 2030. The market is driven by several factors, such as the rising number of lung cancer cases, advancements in targeted therapies and im... Read More »
February 2025The global pharmaceutical market size was estimated at USD 1,645.75 billion in 2024 and is expected to grow at a CAGR of 6.12% from 2025 to 2030. The market is driven by rising chronic disease prevalence, aging populations, and increased healthcare spending. Advancements in biologics, pe... Read More »
February 2025The global peptide drug conjugates market size was valued at USD 3.73 billion in 2024 and is expected to grow at a CAGR of 19.21% from 2025 to 2030. The industry is driven by increasing cancer prevalence, growing demand for targeted therapies, and advancements in peptide synthesis techno... Read More »
February 2025The global liver cancer drug market size was valued at USD 3.67 billion in 2024 and is projected to grow at a CAGR of 17.9% from 2025 to 2030. The rising prevalence of liver cancer, advancement in treatment options, growing awareness and early diagnosis, rising healthcare expenditure, te... Read More »
February 2025The global prostate cancer therapeutics market size was valued at USD 13.4 billion in 2024 and is expected to grow at a CAGR of 8.6% from 2025 to 2030. This growth is driven by factors such as the rising cases of prostate cancer, advancements in screening and diagnostic methods, and gove... Read More »
February 2025The global inhalable biologics market size was estimated at USD 3.79 billion in 2024 and is projected to grow at a CAGR of 17.6% from 2025 to 2030. The market is driven by the growing prevalence of respiratory diseases, increasing demand for non-invasive drug delivery, and advancements i... Read More »
February 2025The global personalized testing & supplements market size was estimated at USD 11.77 billion in 2024 and is projected to witness a CAGR of 16.18% from 2025 to 2030. The market has experienced significant growth due to the increasing consumer demand for tailored health solutions. As p... Read More »
February 2025The global vitamin K2 market size was estimated at USD 292.4 million in 2024 and is projected to grow at a CAGR of 13.5% from 2025 to 2030. Increasing consumer awareness of the health benefits of Vitamin K2, along with demographic factors such as an aging population, changing dietary pre... Read More »
February 2025The global anxiety disorders and depression treatment market size was estimated at USD 15.43 billion in 2024 and is projected to grow at a CAGR of 3.8% from 2025 to 2030. Collaboration among pharmaceutical companies, non-governmental organizations (NGOs), and mental health organizations ... Read More »
February 2025The global celiac disease treatment market size was estimated at USD 690.2 million in 2024 and is projected to grow at a CAGR of 11.7% from 2025 to 2030. Foremost among these is the escalating prevalence of diagnosed celiac disease cases globally. According to recent estimates, approxima... Read More »
February 2025The global dementia treatment market size was estimated at USD 18.03 billion in 2024 and is projected to grow at a CAGR of 8.0% from 2025 to 2030. The market growth is attributed to the high disease prevalence, rising geriatric population, introduction of novel therapeutic products, and ... Read More »
February 2025The global anti-counterfeit pharmaceutical and cosmetic packaging market size was estimated at USD 102.45 billion in 2024 and is expected to grow at a CAGR of 8.65% from 2025 to 2030. Consumers are increasingly prioritizing genuine pharmaceutical and cosmetic products due to health and s... Read More »
February 2025The global pharmaceutical lipid-based excipients market size was estimated at USD 1.82 billion in 2024 and is projected to grow at a CAGR of 4.8% from 2025 to 2030. The growing prevalence of poorly soluble drug candidates, which account for nearly 39% of marketed drugs and 87% of pipelin... Read More »
February 2025